Atlas Trials

Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments

Clinical trial NCT00920205 · COMPLETED

Trial details

NCT number
NCT00920205
Sponsor
Myrexis Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2009-06-01
Primary completion
2011-06-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.